Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × ENT Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 468 Colorectal Neoplasms 205 Neoplasms 198 Prostatic Neoplasms 181 Carcinoma, Non-Small-Cell Lung 164 Stomach Neoplasms 138 Carcinoma, Hepatocellular 128 Leukemia, Myeloid, Acute 125 Rectal Neoplasms 115 Multiple Myeloma 113 Lung Neoplasms 112 Nasopharyngeal Carcinoma 102 Colonic Neoplasms 91 Neoplasm Metastasis 88 Precursor Cell Lymphoblastic Leukemia-Lymphoma 75 Lymphoma 73 Pancreatic Neoplasms 72 Head and Neck Neoplasms 66 Brain Neoplasms 66 Leukemia 65 Uterine Cervical Neoplasms 64 Lymphoma, Large B-Cell, Diffuse 63 Esophageal Neoplasms 63 Lymphoma, Follicular 61 Ovarian Neoplasms 57 Recurrence 54 Squamous Cell Carcinoma of Head and Neck 51 Urinary Bladder Neoplasms 48 Lymphoma, Non-Hodgkin 47 Pain 46

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02246244 2016-06-10

TADDOR

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

ENT Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡